0001885582-21-000001.txt : 20211004 0001885582-21-000001.hdr.sgml : 20211004 20211004100529 ACCESSION NUMBER: 0001885582-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211004 DATE AS OF CHANGE: 20211004 EFFECTIVENESS DATE: 20211004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lowell Therapeutics, Inc CENTRAL INDEX KEY: 0001885582 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-415500 FILM NUMBER: 211301301 BUSINESS ADDRESS: STREET 1: 110 CANAL STREET CITY: LOWELL STATE: MA ZIP: 01852 BUSINESS PHONE: (978) 649-4841 MAIL ADDRESS: STREET 1: 110 CANAL STREET CITY: LOWELL STATE: MA ZIP: 01852 D 1 primary_doc.xml X0708 D LIVE 0001885582 Lowell Therapeutics, Inc 110 CANAL STREET 3RD FLOOR LOWELL MA MASSACHUSETTS 01852 (978) 649-4841 DELAWARE None None Corporation true 2018 JAMES WILKIE 110 CANAL STREET 3RD FLOOR LOWELL MA MASSACHUSETTS 01852 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-09-20 false true false 0 7000000 3846296 3153704 Additional shares to be sold at subsequent closings. false 7 0 0 0 false Lowell Therapeutics, Inc /s/ James Wilkie James Wilkie President 2021-10-01